Page last updated: 2024-08-17

barbituric acid and Non-alcoholic Fatty Liver Disease

barbituric acid has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, L; Chen, T; Chen, Z; Ding, Y; Li, S; Lin, L; Ma, L; Peng, A; Qiu, N; Wang, G; Wei, Y; Xu, Q; Yang, J; Ye, X; Zheng, H1
Chen, L; Chen, Z; Cheng, L; Deng, C; Jiang, W; Li, S; Ma, L; Xiang, M; Xie, C; Zheng, H1

Other Studies

2 other study(ies) available for barbituric acid and Non-alcoholic Fatty Liver Disease

ArticleYear
Synthesis and biological activity of novel barbituric and thiobarbituric acid derivatives against non-alcoholic fatty liver disease.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiponectin; Animals; Barbiturates; Cell Differentiation; Disease Models, Animal; Fatty Liver; Leptin; Male; Mice; Molecular Structure; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship; Thiobarbiturates

2011
A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.
    European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3

    Topics: 3T3-L1 Cells; Adipocytes; Adipokines; AMP-Activated Protein Kinases; Animals; Barbiturates; Carnitine O-Palmitoyltransferase; Cell Differentiation; Down-Regulation; Fatty Liver; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Glucose; Hep G2 Cells; Humans; Insulin Resistance; Liver; Male; Malondialdehyde; Mice; Non-alcoholic Fatty Liver Disease; PPAR gamma; Rats; Rats, Wistar; Triglycerides; Up-Regulation

2011